Arrowhead Research | ARWR - 이자 수익

주가
73.80
매일 변경
-0.11 -0.15%
매월
28.01%
매년
445.86%
Q2 예상
72.33




이자 수익 변화 날짜
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Arrowhead Research USD 9.05M 1.97M 2025-09
Heron Therapeutics USD 433K 277K 2021-12
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Ligand Pharmaceuticals USD 3.87M 2.25M 2025-09
Merck USD 96M 27M 2025-09
Moderna USD 73M 8M 2025-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09
Xencor USD 6.54M 710K 2025-09